AVEO PHARMACEUTICALS INC 4
4 · AVEO PHARMACEUTICALS INC · Filed Oct 4, 2013
Insider Transaction Report
Form 4
Johnston David Brannon
Chief Financial Officer
Transactions
- Disposition to Issuer
Common Stock
2013-10-02−52,200→ 46,837 total
Footnotes (2)
- [F1]Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of two awards of restricted stock granted to the reporting person on January 31, 2012 and January 24, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
- [F2]Includes 3094 shares acquired on June 28, 2013 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.